North America Digital Genome Market Report 2021: Continuous Funding by the Manufacturers and Government in the Field of Genomics – Forecast to 2028 -…

Dublin, March 15, 2021 (GLOBE NEWSWIRE) -- The "North America Digital Genome Market 2021-2028" report has been added to ResearchAndMarkets.com's offering.

North America market for digital genome is expected to rise with a CAGR of 9.75%

The United States dominates North America's genome editing market. The high rate of adoption of advanced technology, the presence of big industry names, high funds for genomic research are all factors attributable to the major share of the country in this market.

Further, extensive research activities in genomics, gene editing, cell line culture, and modification are being conducted, which is boosting the market growth in the US. Several globally-renowned manufacturers of DNA sequencing technologies, equipment, and platforms are active in the US.

For instance, several prominent names in the DNA sequencing industry, such as Thermo Fisher Scientific, Illumina, and others have their corporate presence in the nation, and the enhanced adoption of DNA sequencing has led to a rise in the creation of genomic databases like Ensembl Human Genome Server, UCSC Human Genome Browser Gateway, and others. These factors are projected to drive the digital genome market in the US.

In addition, factors like growing awareness of DNA sequencing, and its applications in different fields, including personalized medicine, clinical diseases, agri-genomics, and others, are contributing to market progress.

COMPETITIVE OUTLOOK

Some of the companies present in this market include Oxford Nanopore Technologies Ltd, Inscripta, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company (BD), Pacific Bioscience, and Abbott Laboratories.

Key Topics Covered:

1. North America Digital Genome Market - Summary

2. Industry Outlook2.1. Porter's Five Forces Model2.2. Impact of Covid-19 on Digital Genome Market2.3. Market Attractiveness Index2.4. Vendor Landscape2.5. Key Insights2.6. Key Drivers2.6.1. Proliferating Burden of Chronic Diseases2.6.2. Continuous Funding by the Manufacturers and Government in the Field of Genomics2.7. Key Restraints2.7.1. Security Risks Associated With Digital Genome2.7.2. Lack of Skilled Professionals in the Field of Genome Technology2.8. Key Opportunities2.8.1. Technological Advancements2.8.2. Prevailing Awareness in the Developing Economies Regarding Dna Sequencing Technologies

3. Digital Genome Market Outlook - by Product3.1. Sequencing and Analyzer Instruments3.2. Dna/Rna Analysis3.3. Sequencing and Analysis Software3.4. Sequencing Chips3.5. Sample Prep Instruments

4. Digital Genome Market Outlook - by Application4.1. Diagnostics4.2. Drug Discovery4.3. Academic Research4.4. Personalized Medicine4.5. Agricultural4.6. Other Applications

5. Digital Genome Market Outlook - by End-User5.1. Diagnostics and Forensic Labs5.2. Academic Research Institutes5.3. Hospitals5.4. Other End-Users

6. Digital Genome Market - North America6.1. Country Analysis6.1.1. The United States6.1.2. Canada

7. Company Profile7.1. Qiagen Nv7.2. Oxford Nanopore Technologies Ltd7.3. Becton, Dickinson, and Company (Bd)7.4. Illumina Inc7.5. Thermo Fisher Scientific Inc7.6. Pacific Bioscience7.7. Bio-Rad Laboratories Inc7.8. F. Hoffmann-La Roche7.9. Perkinelmer Inc7.10. Regeneron Pharmaceuticals7.11. Biomerieux Sa7.12. Abbott Laboratories7.13. Agilent Technologies Inc.7.14. Inscripta

8. Research Methodology & Scope

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/jweemt

See the original post here:
North America Digital Genome Market Report 2021: Continuous Funding by the Manufacturers and Government in the Field of Genomics - Forecast to 2028 -...